CompletedPhase 4

Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder

United States50 participantsStarted 2006-09

Plain-language summary

The purpose of this study is to determine whether treating sleep difficulties in patients with seasonal affective disorder also improves their depressive symptoms.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female age 18-65 yrs. * A diagnosis of seasonal affective disorder * A Pittsburgh Sleep Quality Index \>5 * English speaking * Be able to sign informed consent Exclusion Criteria: * Active substance abuse * Current psychotic symptoms * Severe personality disorders * Primary sleep disorders * Severe chronic obstructive pulmonary disease (COPD) * Prescription fluvoxamine(Luvox) use

What they're measuring

Sleep Satisfaction at Baseline and Measured Monthly, as Measured by the Pittsburgh Sleep Quality Index (PSQI)

Timeframe: Monthly for duration of treatment (up to 4 months)

Trial details

NCT IDNCT00502320

SponsorLehigh Valley Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-04

Results submitted2009-07-21

View on ClinicalTrials.gov More Seasonal Affective Disorder trials